Advanced search
Publication Cover
Autoimmunity Volume 35, 2002 - Issue 4
Submit an article Journal homepage
28
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Effect of Halofuginone on the Development of Tight Skin (TSK) Syndrome

Tracy McGaha Department of Microbiology, The Mount Sinai School of Medicine, Box 1124, One Gustave L. Levy Place, New York, NY 10029, USA
,
Takao Kodera Department of Microbiology, The Mount Sinai School of Medicine, Box 1124, One Gustave L. Levy Place, New York, NY 10029, USA
,
Robert Phelps Department of Pathology, The Mount Sinai School of Medicine, Box 1124, One Gustave L. Levy Place, New York, NY 10029, USA
,
Harry Spiera Department of Medicine, The Mount Sinai School of Medicine, Box 1124, One Gustave L. Levy Place, New York NY 10029, USA
,
Mark Pines Institute of Animal Science, The Volcani Center, Bet Degan, Israel
&
Constantin Bona Department of Microbiology, The Mount Sinai School of Medicine, Box 1124, One Gustave L. Levy Place, New York, NY 10029, USA
Pages 277-282 | Published online: 07 Jul 2009

  • Varga, J. and Bashey, R.I. (1995) "Regulation of connective tissue synthesis in systemic sclerosis", Intern. Rev. Immunol. 12, 187 - 199
  • Bona, C. and Rothfield, N. (1994) "Autoantibodies in scleroderma and tight skin mice", Curr. Opin. Immunol. 6, 931 - 939
  • Bona, C. (2000) "Anti-fibrillin autoantibodies in scleroderma and MCTD diseases", In: Conrad, K., Humbel, R-L., Shoenfeld, Y. and Tan, E.M., eds, Autoantigens and Autoantibodies (Pabst Lengerich, Berlin), pp 677 - 680
  • Sakai, L.Y., Keene, D.R. and Engvall, E. (1996) "A new 350-kD glycoprotein is a new component of extracellular microfibrils", J. Cell. Biol. 103, 2499 - 2509
  • Seibold, J.R., Korn, J.H., Simms, R. and Clemens, P.J. (2000) "Recombinant human relaxin in the treatment of scleroderma. A randomized, double blind, placebo-controlled trial", Ann. Intern. Med. 132, 871 - 879
  • Nimni, M.E. (1968) "A defect in the intramolecular and intermolecular cross-linking of collagen caused by penicillamine. I. Metabolic and functional abnormalities in soft tissues", J. Biol. Chem. 243, 1457 - 1466
  • Keiser, H.R. and Sjoerdsma, A. (1967) "Studies on beta-aminopropionitrile in patients with scleroderma", Clin. Pharmacol. Ther. 4, 593 - 602
  • Stratton, R., Shiven, X., Martini, G., Holmes, A., Leask, A., Haberberger, T., Martin, G.R., Black, C.M. and Abraham, D. (2001) "Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients", J. Clin. Investig. 108, 241 - 250
  • Casas, J.A., Subauste, C.P. and Alcaron, G.S. (1987) "A new promising treatment in systemic sclerosis: 5-fluorouracil", Ann. Rheum. Dis. 46, 763 - 767
  • Granot, I., Halevy, O., Hurwitz, S. and Pines, M. (1993) "Halofuginone: an inhibitor of collagen type I synthesis", Biochem. Biophys. Acta 1156, 107 - 112
  • Levy-Schaffer, F., Nagler, A., Slavin, S., Knopov, V. and Pines, M. (1996) "Inhibition of collagen synthesis and changes in skin morphology in murine graft versus host diseases: effect of halofuginone", J. Investig. Dermatol. 106, 84 - 88
  • Nagler, A. and Pines, M. (1999) "Topical treatment of cutaneous graft versus host disease (cGVHD) with halofuginone: a novel inhibitor of collagen type I synthesis", Transplantation 68, 1806 - 1809
  • Nagler, A., Firman, N., Feferman, R., Cotev, S., Pines, M. and Shosan, S. (1996) "Reduction of pulmonary fibrosis in vivo by halofuginone", Am. J. Respir. Crit. Care Med. 154, 1082 - 1086
  • Pines, M., Knopov, V., Genina, O., Lavelin, I. and Nagler, A. (1997) "Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis", J. Hepatol. 27 (2), 391 - 398
  • Green, M.C., Sweet, O. and Bunker, L.E. (1976) "Tight skin, a new mutation in the mouse causing excessive growth of connective tissue and skeleton", Am. J. Pathol. 82, 493 - 512
  • Muryoi, T., Kasturi, K.N., Kafina, M., Cram, B.S., Harrison, L.C., Sasaki, T. and Bona, C. (1992) "Anti-topoisomerase I monoclonal antibodies from scleroderma patients and tight skin mouse interact with the same epitopes", J. Exp. Med. 175, 1109 - 1115
  • Shibata, S., Muryoi, T., Saitoh, Y., Brumeanu, T.D., Bona, C. and Kasturi, K.N. (1993) "Immunochemical and molecular characterization of anti-RNA polymerase I autoantibodies produced by tight-skin mice", J. Clin. Investig. 92, 984 - 995
  • Muryoi, T., Andre-Schwartz, J., Saitoh, Y., Daian, C., Hall, B., Dimitriu-Bona, A., Schwartz, R.S., Bona, C. and Kasturi, K.N. (1992) "Self-reactive repertoire of tight skin mouse: immunochemical and molecular characterization of anti-cellular antibodies", Cell. Immunol. 143, 43 - 55
  • Murai, C., Saito, I., Kasturi, K.N. and Bona, C. (1998) "Spontaneous occurrence of anti-fibrillin-1 autoantibodies in tight skin mice", Autoimmunity 28, 151 - 155
  • McGaha, T.L., Phelps, R.G., Spiera, H. and Bona, C. (2002) "Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks TGF-β mediated Smad3 activation in fibroblasts", J. Investig. Dermatol., 118, 461 - 470
  • Siracusa, L., McGrath, R., Ma, Q., Moskow, J.J., Manne, J., Christner, P.J., Buckberg, A.M. and Jimenez, S.A. (1996) "A tandem duplication within the fibrillin-1 gene is associated with tight skin mutation", Genome Res. 6, 300 - 313
  • Bona, C. (1999) "Genetic defects in tight skin mice developing a scleroderma-like syndrome", Curr. Dir. Autoimmun. 1, 194 - 207
  • Bruck, R., Genina, O., Aeed, H., Nagler, A., Avini, Y. and Pines, M. (2001) "Halofuginone to prevent and treat thioacetamide-induced liver fibrosis", Hepatology 33, 379 - 386
  • Hatakeyama, A., Kasturi, K.N., Wolf, I., Phelps, R.G. and Bona, C.A. (1996) "Correlation between the concentration of serum anti-topoisomerase 1 autoantibodies and histological and biochemical alterations in the skin of tight skin mice", Cell. Immunol. 167, 135 - 140
  • Nyska, M., Nyska, A., Rivlin, E., Porat, S., Pines, M., Shoshan, S. and Nagler, A. (1996) "Topically applied halofuginone, an inhibitor of collagen type-I transcription, reduces peritnedinous fibrous adhesions following surgery", Connect. Tiss. Res. 34 (2), 97 - 103
  • Rossi, G.A., Hunninghake, G.W., Gadek, J.E., Szapiel, S.U., Kawamani, O., Ferrons, V.J. and Crystal, R.G. (1984) "Hereditary emphysema in tight skin mice", Am. Rev. Respir. Dis. 129, 850 - 855
  • Nagler, A., Genina, O., Lavelin, I., Ohana, M. and Pines, M. (1999) "Halofuginone, an inhibitor of collagen type I synthesis prevents postoperative adhesion formation in the rat uterine horn model", Am. J. Obstet. Gynecol. 80, 558 - 563
  • Saito, S., Nishimura, H., Phelps, R.G., Wolf, I., Miato, S., Honjo, T. and Bona, C.A. (2000) "Induction of skin fibrosis in mice expressing a mutated Fibrillin-1 gene", Mol. Med. 6, 1942 - 1952
  • McGaha, T., Saito, S., Phelps, R.G., Gordon, R., Noben-Trauth, N., Paul, W.E. and Bona, C. (2001) "Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4Rα and transforming growth factor-β genes", J. Investig. Dermatol. 116, 136 - 143
  • Kodera, T., McGaha, T.L., Phelps, R., Paul, W.E. and Bona, C.A. (2002) "Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblasts", Proc. Natl Acad. Sci. USA, 99, 3800 - 3805
  • Casciola-Rosen, L., Wigley, F. and Rosen, A. (1997) "Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions", J. Exp. Med. 185, 71 - 79
  • Gayraud, B., Keene, D.R., Sakai, L.Y. and Ramirez, F. (2000) "New insights into the assembly of extracellular microfibrils from the analysis of the fibrillin 1 mutation in the tight skin mouse", J. Cell Biol. 150 (3), 667 - 679
  • Wallis, D.D., Tan, F.K., Kielty, C.M., Kimball, M.D., Arnett, F.C. and Milewicz, D.M. (2001) "Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma)", Arthritis Rheum. 44 (8), 1855 - 1864

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.